ATE122720T1 - Virales vektorsystem zum einführen fremder dns- expressionserzeugnisse in gallinaceenvögeln. - Google Patents

Virales vektorsystem zum einführen fremder dns- expressionserzeugnisse in gallinaceenvögeln.

Info

Publication number
ATE122720T1
ATE122720T1 AT88903647T AT88903647T ATE122720T1 AT E122720 T1 ATE122720 T1 AT E122720T1 AT 88903647 T AT88903647 T AT 88903647T AT 88903647 T AT88903647 T AT 88903647T AT E122720 T1 ATE122720 T1 AT E122720T1
Authority
AT
Austria
Prior art keywords
foreign dna
viral vector
vector system
expression products
dna expression
Prior art date
Application number
AT88903647T
Other languages
English (en)
Inventor
Sandra Martin
Pradip Bandyopadhyay
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21839402&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE122720(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synergen Inc filed Critical Synergen Inc
Application granted granted Critical
Publication of ATE122720T1 publication Critical patent/ATE122720T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88903647T 1987-03-19 1988-03-21 Virales vektorsystem zum einführen fremder dns- expressionserzeugnisse in gallinaceenvögeln. ATE122720T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2772487A 1987-03-19 1987-03-19

Publications (1)

Publication Number Publication Date
ATE122720T1 true ATE122720T1 (de) 1995-06-15

Family

ID=21839402

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88903647T ATE122720T1 (de) 1987-03-19 1988-03-21 Virales vektorsystem zum einführen fremder dns- expressionserzeugnisse in gallinaceenvögeln.

Country Status (6)

Country Link
EP (1) EP0351418B1 (de)
JP (1) JPH02502693A (de)
AT (1) ATE122720T1 (de)
AU (1) AU619181B2 (de)
DE (1) DE3853819T2 (de)
WO (1) WO1988007088A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US5928648A (en) * 1985-09-06 1999-07-27 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
EP0354213A1 (de) * 1987-03-09 1990-02-14 The Upjohn Company Gegen virale infektionen resistente transgene tierzellen
JP2779447B2 (ja) * 1988-03-20 1998-07-23 財団法人阪大微生物病研究会 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
GB8821441D0 (en) 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
WO1990002803A2 (en) * 1988-09-13 1990-03-22 Rhone-Merieux S.A. Viral vaccines
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
US5231023A (en) * 1990-07-30 1993-07-27 Akzo N.V. Recombinant Marek's disease virus
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
DK0775746T3 (da) 1995-07-03 2006-04-03 Akzo Nobel Nv Vaccine mod fjerkræcoccidiose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0231209B1 (de) * 1985-07-29 1991-02-06 The Upjohn Company Virus-impfstoff
US5068192A (en) * 1986-01-27 1991-11-26 Prutech Research And Development Partnership Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence
AU623333B2 (en) * 1986-01-27 1992-05-14 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
DE3854190T2 (de) * 1987-07-27 1996-03-28 Syntro Corp Attenuierte herpesviren, herpesviren, die für eine aminosäuresequenz kodierende fremde dns beeinhalten und sie enthaltende impfstoffe.

Also Published As

Publication number Publication date
JPH02502693A (ja) 1990-08-30
AU1578788A (en) 1988-10-10
EP0351418B1 (de) 1995-05-17
EP0351418A1 (de) 1990-01-24
DE3853819T2 (de) 1995-09-21
EP0351418A4 (de) 1990-06-27
AU619181B2 (en) 1992-01-23
DE3853819D1 (de) 1995-06-22
WO1988007088A1 (en) 1988-09-22

Similar Documents

Publication Publication Date Title
DE3853819D1 (de) Virales vektorsystem zum einführen fremder dns-expressionserzeugnisse in gallinaceenvögeln.
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
NZ227177A (en) Vectors and dna compounds for the expression of human protein c
DE3689447D1 (de) Rekombinantes Viren-Überzugsprotein assoziiert mit "Acquired Immune Deficiency Syndrome" (AIDS) und Verfahren zur Testung von AIDS.
ATE188740T1 (de) Viruspartikel mit veraendertem wirtspektrum
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
NZ218586A (en) Extraction of proteins by solubilisation
UA91675C2 (ru) Формула полинуклеотидной вакцины против дыхательных паталогий и паталогий размножения свиней
AU2445888A (en) Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ZA909570B (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
PT82651A (en) Process for preparing synthetic vaccines for foot and mouth disease based on peptides
IL91234A0 (en) Hybrid protein c constructs and methods for their preparation
EP0481072A4 (en) Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
HUT68379A (en) Method for modifying the cell, tissue or host tropism of a recombinant microorganism obtained this way and use thereof in medicine and veterinary medicine
IL88095A0 (en) Dna sequences,proteins and gene preparations
GB2211389B (en) Procedure for the treatment of pigs in slaughterhouses, and system for the stalling of pigs
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ES513947A0 (es) Procedimiento para la preparacion de un vector hibrido y la clonacion de adn-ajeno en organismos hospetantes.
SE8100581L (sv) Gen och underenhet till densamma, plastmidvektor innehallande denna gen eller ungerenhet, forfarande for genens, underenhetens och vektorns framstellning och anvendning samt salunda erhallna celler och interferonlikn...
NO178870C (no) Fremgangsmåte for fremstilling av modifisert Eglin B eller C samt DNA, ekspresjonsvektor og vertsmikroorganisme
ZA874677B (en) Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
GEP20012489B (en) Use of Natural Human α-Interferon
DE3782350D1 (de) Rekombinante parvovirus-ra-1-produkte und verfahren zu deren anwendung.
SE8205247L (sv) Fiskvacciner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee